Screening for PRÊT1D is shifting into high gear!
PRÊT1D SCREENING IS SHIFTING INTO HIGH GEAR! THE NEW KEY MILESTONES OF THE STUDY 22 of the 28 centers in the INNODIA pilot phase…

«Promoting and supporting research on diabetes
and metabolic diseases»
For the advancement of diabetes research
‼️ DISCOVER THE 2026 WINNERS ‼️
The scientific Council of the Francophone Foundation for Diabetes Research – FFRD – has made its decision! 2026 marks its 13th call for proposals with nearly 40 applicants…
🚦 Since 2013, it means a total of:
🙏 The FFRD thanks its faithful partners, supporters and donors, aind is proud to dedicate more than 80% of its expenditures to the research on diabetes in Francophonie!
🚨 Opening of the next FFRD call for proposals on December 1, 2026 🚨
⚠️ DISCOVER THE NEW PROCESS ⚠️
🎯 Promoting and supporting diabetes research, its mechanisms, prevention, management, comorbidities and complications…
For the advancement of diabetes research and REDUCE THE BURDEN OF THE DISEASE 🩸
PRÊT1D SCREENING IS SHIFTING INTO HIGH GEAR! THE NEW KEY MILESTONES OF THE STUDY 22 of the 28 centers in the INNODIA pilot phase…
Let’s meet the FFRD at Village des Associations
Alongside our partner, the SFD
Overview of 2026 and projections for 2027
Preparing the Board of Directors Meeting
Proposition of the 2027 Agenda

The Francophone Foundation for Diabetes Research (FFRD) serves as the “armed wing” of the Francophone Diabetes Society (SFD) with the aim of promoting excellence in diabetes research, a common disease whose prevalence continues to rise. High-level and large-scale research is truly essential to get further insight into the mechanisms involved in the development of diabetes and its complications, as well as to improve their treatment and prevention.
The FFRD supports clinical, basic, and translational research.
The supported basic research projects address major themes of type 1 and type 2 diabetes
covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.
The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes
and often involve large multicenter cohort studies.
Since 2013, the Foundation has been:

